iShares NASDAQ Biotechnology Index ETF (IBB) Puts Fly Amid Sector Swoon

Drugmaker stocks are taking it on the chin today, as evidenced by the sinking iShares NASDAQ Biotechnology Index ETF (NASDAQ:IBB)

Jan 11, 2016 at 2:54 PM
facebook X logo linkedin


Biotech stocks are getting hammered today (which happens to coincide with the kickoff of the J.P. Morgan Healthcare Conference). Case in point, the iShares NASDAQ Biotechnology Index ETF (NASDAQ:IBB) has slid 4.2% to trade at $289.50, on pace for its eighth straight drop. Not surprisingly, put traders have set their sights on the exchange-traded fund (ETF), in hopes of more drugmaker downside.

By the numbers, 11,000 IBB puts are on the tape versus 6,500 calls. For some more perspective, consider that at this point in a typical session, fewer than 5,000 puts would have been traded. Digging deeper, the most active option is the January 2016 280-strike put, and traders buying to open positions foresee a move south of $280 -- and into annual-low territory -- by this Friday's close, when the options expire.

Put buying is nothing new for IBB speculators. During the past two weeks across the International Securities Exchange (ISE), Chicago Board Options Exchange (CBOE), and NASDAQ OMX PHLX (PHLX), 2.55 puts have been bought to open for each call. Relative to all comparable readings taken in the prior year, the current put/call volume ratio registers in the high 84th percentile. Stated simply, traders have rarely initiated long puts over calls at a more rapid rate, looking back 12 months.

It isn't a bad time to buy premium on short-term IBB strikes, either. The ETF's Schaeffer's Volatility Index (SVI) of 32% ranks below 69% of all other readings taken in the past year, suggesting options in the front three-months' series are relatively inexpensive, from a volatility perspective.

Meanwhile, from a technical standpoint, it's no wonder traders are placing downside bets on the iShares NASDAQ Biotechnology Index ETF (NASDAQ:IBB). Since hitting a record high of $400.79 last July, the shares have surrendered over one-quarter of their value, though the $285 region has contained the ETF's pullbacks.
 

Target Effortless Triple-Digit Gains Every Sunday Evening For Life!

This is your chance to triple your profit potential on Sunday evenings, without spending all your free time watching the market.

On Sundays, as a Weekend Plus subscriber, you’ll get up to 6 trades every Sunday, each targeting gains of 200% or more.

Start targeting gains like the ones our subscribers have seen recently, including:

213.3% GAIN on AutoNation calls
100.0% GAIN on Monster Beverage calls
100.4% GAIN on Walgreens Boots Alliance puts
100.4% GAIN on ON Semiconductor calls
257.7% GAIN on Dell calls

101.0% GAIN on Apollo Global Management calls
103.6% GAIN on JP Morgan  Chase calls
105.3% GAIN on DraftKings calls
101.3% GAIN on Airbnb calls
203.0% GAIN on Shopify calls
102.0% GAIN on Cboe Global Markets calls
100.9% GAIN on Boeing calls
102.1% GAIN on Microsoft puts
102.3% GAIN on First Solar calls
101.5% GAIN on PulteGroup calls
101.0% GAIN on Apple calls
209.4% GAIN on NXP Semiconductors calls
100.8% GAIN on Uber Technologies calls
100.4% GAIN on Academy Sports and Outdoors puts
102.2% GAIN on Trade Desk calls
100.8% GAIN on DoorDash calls
100.0% GAIN on Camping World Holdings puts
100.0% GAIN on Cboe Global Markets calls
100.2% GAIN on C3.ai calls
238.5% GAIN on Oracle calls

 
 
 


 
 

Rainmaker Ads CGI